BlackRock Institutional Trust’s GALENA BIOPHARMA INC COM RXII Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | – | Sell |
-4,398,909
| Closed | -$1.54M | – | 3971 |
|
|
2016
Q3 | $1.54M | Buy |
4,398,909
+246,804
| +6% | +$86.5K | ﹤0.01% | 3145 |
|
|
2016
Q2 | $1.94M | Sell |
4,152,105
-45,903
| -1% | -$21.4K | ﹤0.01% | 3058 |
|
|
2016
Q1 | $5.71M | Buy |
4,198,008
+147,585
| +4% | +$201K | ﹤0.01% | 2589 |
|
|
2015
Q4 | $5.95M | Buy |
4,050,423
+87,696
| +2% | +$129K | ﹤0.01% | 2622 |
|
|
2015
Q3 | $6.26M | Sell |
3,962,727
-234,274
| -6% | -$370K | ﹤0.01% | 2589 |
|
|
2015
Q2 | $7.13M | Sell |
4,197,001
-56,437
| -1% | -$95.9K | ﹤0.01% | 2589 |
|
|
2015
Q1 | $5.91M | Buy |
4,253,438
+172,887
| +4% | +$240K | ﹤0.01% | 2697 |
|
|
2014
Q4 | $6.16M | Buy |
4,080,551
+101,910
| +3% | +$154K | ﹤0.01% | 2633 |
|
|
2014
Q3 | $8.2M | Buy |
3,978,641
+129,663
| +3% | +$267K | ﹤0.01% | 2451 |
|
|
2014
Q2 | $11.8M | Buy |
3,848,978
+220,445
| +6% | +$675K | ﹤0.01% | 2327 |
|
|
2014
Q1 | $9.07M | Buy |
3,628,533
+113,736
| +3% | +$284K | ﹤0.01% | 2484 |
|
|
2013
Q4 | $17.4M | Sell |
3,514,797
-144,556
| -4% | -$717K | ﹤0.01% | 2052 |
|
|
2013
Q3 | $8.34M | Buy |
3,659,353
+867,535
| +31% | +$1.98M | ﹤0.01% | 2470 |
|
|
2013
Q2 | $6.2M | Buy |
+2,791,818
| New | +$6.2M | ﹤0.01% | 2587 |
|
BlackRock Institutional Trust's RXII Position: Q4 2016 in Review
BlackRock Institutional Trust sold out of GALENA BIOPHARMA INC COM (RXII) in Q4 2016, closing a stake of 4,398,909 shares — an estimated $1.54M sold.
BlackRock Institutional Trust first reported a position in RXII in Q2 2013 and held it in 14 quarters. The position peaked at $17.4M in Q4 2013. 0 funds tracked by Wall St. Rank hold RXII as of Q4 2016.
- BlackRock Institutional Trust reported no remaining GALENA BIOPHARMA INC COM position as of Q4 2016 after selling out during the quarter.
- BlackRock Institutional Trust sold 4,398,909 GALENA BIOPHARMA INC COM shares in Q4 2016, an estimated $1.54M.
- BlackRock Institutional Trust first reported a position in GALENA BIOPHARMA INC COM in Q2 2013 and held it in 14 quarters.
- BlackRock Institutional Trust's GALENA BIOPHARMA INC COM position peaked at $17.4M in Q4 2013.
- 0 funds tracked by Wall St. Rank held GALENA BIOPHARMA INC COM as of Q4 2016.
Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.